Skip to content

Impact of specific physcail therapy treatment on the health of patients with Parkinson's disease

Effects of cognitive-motor rehabilitation on non-motor symptoms of patients with Parkinson's disease: a controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-56brsc
Enrollment
Unknown
Registered
2014-04-30
Start date
2014-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Group 1 (n = 10): 10 patients with Parkinson’s disease will participate in a program of cognitive-motor exercises, with activities performed in group. Group 2 (n = 10): 10 patients with Parkinson’s di
Other
H02.010.625
F01.145.632
HP6.051.376.162
E02.779.483

Sponsors

Universidade Federal de Mato Grosso do Sul
Lead Sponsor
Universidade Federal de Mato Grosso do Sul
Collaborator

Eligibility

Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: Volunteers of both gender, aged between 60 and 90 years, diagnosed with idiopathic Parkins's disease, with clinical profile indicating moderate impairment based on the Hoehn–Yarh scale and on the motor subscale of the Unified Parkinson's Disease Rating Scale

Exclusion criteria

Exclusion criteria: Patients with cognitive decline, those with movement disorders not compatible with a diagnosis of idiopathic Parkinson's disease (such as secondary Parkinsonism), subjects with congenital or acquired amaurosis and those with severe cardiovascular and musculoskeletal comorbidities that preclude orthostatism and deambulation.

Design outcomes

Primary

MeasureTime frame
Improvement in health indeces (cognitive functions, functionality and quality of life), verified by means of the longitudinal analysis promoted by the Repeated Measures Analysis of Variances, with p<0.05 and statistical power of 80%.

Secondary

MeasureTime frame
Maintenance/improvement of cognitive functions, functionality and quality of life. The verification shall be accomplished by the following instruments: Wisconsin Card Sorting Testt, Mini-Mental State Examination, Raven test, Parkinson's Desease Questionnare (PDQ-39) and Pfeffer Index.

Countries

Brazil

Contacts

Public ContactRenata de Oliveira

UFMS

reoliveira_terra@hotmail.com+55 (67) 8148-8185

Outcome results

None listed

Source: REBEC (via WHO ICTRP)